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Abstract
Background: Plasmodium falciparum placental malaria (PM) contributes to 10,000 maternal deaths due to severe anemia
(SA) each year in Africa, primarily among primigravid women who are most susceptible. Increased levels of proinflammatory
cytokines like TNF-a are associated with maternal anemia in first time mothers but not in other women. Here we aimed to
identify additional changes in the plasma proteome associated with pregnancy malaria that may contribute to the
development of malaria-related maternal anemia.
Principal Findings: A semi-quantitative mass spectrometry approach was used to compare the relative abundance of
plasma proteins in anemic versus non-anemic women with PM. Levels of 24 proteins differed significantly between anemic
and non-anemic primigravidae, including several lipid metabolism proteins and molecular transport proteins involved in the
acute phase response signaling network. These differences were not observed in multigravid women who enjoy specific
immunity that protect them from PM. In a confirmatory study of a larger cohort of primigravid women, levels of the lipid
metabolism protein Apolipoprotein (Apo)-AI were significantly lower in PM+ women with SA.
Conclusions: Apo-AI levels are significantly lower in severely anemic primigravidae with PM, and ApoA1 levels positively
correlate with hemoglobin levels in primigravid but not multigravid women. Apo-AI is known to have anti-inflammatory
effects, and thus Apo-AI reductions may contribute to the inflammatory processes that result in SA.
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Introduction
Severe anemia (SA) is a common consequence of P. falciparum
infection, and is a major cause of childhood and maternal
mortality in Africa [1,2,3]. During pregnancy, P. falciparum-
infected erythrocytes (IE) bind chondroitin sulfate A (CSA) [4]
and accumulate in the placenta. Disease due to placental malaria
(PM) is strongly associated with the macrophage-rich inflamma-
tory infiltrates that sometimes appear in the intervillous spaces of
the placenta. Women are most susceptible to infection, inflam-
mation and disease during first pregnancy (reviewed in [5]), and
become resistant over successive pregnancies as they acquire
antibodies that block IE binding to CSA [6].
Pregnancy is an event of immunologic tolerance, whereby a
woman accepts the implantation of the fetal allograft in her
uterus. Normal placentas display a bias toward type 2 cytokines
[7], but type 1 cytokine levels increase during PM [8,9]. TNF-a
levels increase in primigravid (first pregnancy) and multigravid
(multiple prior pregnancies) women during PM, but are
associated with SA in primigravid women only, suggesting that
unknown factors in addition to TNF-a may be involved in the
pathogenesis of SA [8].
The completion of several genome sequencing projects and the
development of new proteomics tools provide an opportunity to
study global changes associated with specific disease. In general,
disease proteome studies that examine global changes in protein
expression have sought to identify disease biomarkers, new
therapeutic targets, and to understand host-pathogen interactions.
The advantage of this approach is that it is not limited to the
measurement of predicted factors, but instead assesses global
changes associated with disease. This approach has been mainly
used in studies of chronic diseases like cancer and vascular
disease.
Here we report the first analysis of the plasma proteome during
malaria, using samples collected from infected pregnant women
with and without SA. Primigravid but not multigravid women had
significantly altered levels of proteins involved in lipid metabolism
and inflammatory immune responses. Similar changes have
previously been reported in studies of other severe inflammatory
diseases.
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Subjects
Samples used for these studies were collected from women who
delivered at New Nyanza Provincial General Hospital, Kisumu,
Kenya, or at the Muheza Designated District Hospital, Muheza,
Tanzania. Parturients 18 years and older were invited to
participate in the study, and gave signed informed consent after
receiving a study explanation form and oral explanation from a
nurse in their native language. Women with chronic or debilitating
disease were excluded from the study. These studies were
approved by the International Clinical Studies Review Committee
of the Division of Microbiology and Infectious Diseases at the US
National Institutes of Health, and ethical clearance was obtained
from the Institutional Review Board of Seattle Biomedical
Research Institute, the National Institute for Medical Research
in Tanzania and the Kenya Medical Research Institute.
Clinical Data
Clinical information and medical history were recorded by
study nurses using a standard questionnaire. Peripheral blood
samples were collected by venipuncture immediately after delivery
in citrate phosphate dextrose. Malaria infection status at the time
of delivery was determined by microscopic examination of
Giemsa-stained placental and peripheral blood smears. Hemoglo-
bin concentrations were determined using Cell-Dyne 1200
hematology analyzer (Abott Diagnostics, North Chicago, IL,
USA). SA was defined as hemoglobin level of ,7 g/dl in pregnant
women. Plasma was separated by centrifugation, and aliquots were
stored at 280uC.
Sample Selection
For global plasma proteome analysis, samples from malaria-
infected primigravidae and multigravidae with and without SA
were selected from two cohorts of women (Kenya and Tanzania).
For confirmatory studies by ELISA all available samples from
malaria-infected and uninfected primigravid and multigravid
women with SA were analyzed. Samples from the same groups
of women without SA were randomly selected for ELISA
analysis.
Preparation of Plasma Samples for Proteomics Studies
Six high-abundance plasma proteins were depleted using the
Agilent (Palo Alto, CA, USA) Multiple Affinity Removal System
Human 6 LC Column immunoaffinity-based depletion system
according to the manufacturer’s instructions. The proteins
removed were albumin, IgG, IgA, transferrin, haptoglobin, and
antitrypsin. The flow-through fraction containing unbound
proteins was collected and concentrated using a 5 kDa molecular
weight cutoff spin concentrator (Agilent). Samples were denatured
and reduced by adding urea to 8 M, dithiothreitol to 10 mM, and
then incubating for 1 h at 37uC. Cysteines were alkylated by
adding iodoacetamide to 40 mM and then incubating for 1 h at
37uC. The reaction was quenched by adding dithiothreitol to a
final concentration of 50 mM and then incubating for 1 h at 37uC.
After a ten-fold dilution, the reduced and alkylated samples were
digested overnight at 37uC using sequencing grade modified
trypsin (Promega, Madison, WI, USA) at a 1:50 enzyme:protein
(w/w) ratio. The resulting peptide mixtures were de-salted using
DSC-18 solid-phase extraction cartridges (Supelco, Bellefonte, PA,
USA). 500 mg of peptide samples were acidified and fractionated
by strong cation exchange (SCX) chromatography on a
2.16200 mm Polysulfoethyl A column (PolyLC, Columbia, MD,
USA). A gradient from 75% 10 mM formic acid (aq)/25%
acetonitrile (A) to 75% 500 mM ammonium formate (aq)/25%
acetonitrile (B) over 45 min was used to achieve separation.
Fractions containing peptides underwent a final de-salting step
using Vydac C18 Silica solid-phase extraction spin columns (The
Nest Group, Southborough, MA, USA). Peptide concentrations
were determined using a BCA assay kit (Pierce, Rockford, IL,
USA).
LC-MS/MS Analysis
LC-MS/MS was performed using an LTQ linear ion trap mass
spectrometer (ThermoFinnigan, San Jose, CA, USA). The LC
system consisted of a fused-silica nanospray needle packed in-
house with C18 reversed-phase material. 2 mg of total peptide at
0.1 mg/mL were loaded onto the reversed phase column using a
two-mobile-phase solvent system consisting of 0.4% acetic acid in
water (A) and 0.4% acetic acid in acetonitrile (B). The mass
spectrometer operated in a data-dependent MS/MS mode over
the m/z range of 400–1400. For each cycle, the five most
abundant ions from each MS scan were selected for MS/MS
analysis using 20% normalized collision energy. Dynamic
exclusion was used to exclude ions that had been detected twice
in a 30 sec window for 45 seconds.
Data Analysis
Raw MS/MS data were submitted to BioWorks 3.0 (Thermo-
Electron, San Jose, CA, USA) and searched using the Sequest
algorithm against a combined database of human and P. falciparum
3D7 protein sequences. The database was produced by down-
loading all human and P. falciparum 3D7 sequences available from
NCBI GenBank on May 25, 2006 (based on GenBank release
153). Sequest output was analyzed and validated by PeptidePro-
phet [10]. Peptides with a probability score of $0.9 were accepted.
The lists of detected peptides were converted to a list of
corresponding unique genes using the cross-reference table
provided by NCBI (ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/
gene2accession.gz). To estimate the false discovery rate, a reversed
database approach was used [11]. The false discovery rate was
estimated to be ,1% at the mass spectrum level and ,2% at the
peptide level.
Proteins Networks and Functional Analysis
Differential expression of plasma proteins was estimated by
comparing spectrum counts [12,13], and significant differences
determined by Mann-Whitney U test using Statview software (SAS
Inc, Cary, NC, USA).
Protein interaction networks and functions of differentially
expressed proteins were analyzed using Ingenuity Pathways
Analysis (Ingenuity SystemsH, www.ingenuity.com). This program
identifies networks of interacting proteins that are significantly
enriched in the experimental dataset of differentially expressed
proteins. Functional analysis of the dataset for molecular and
cellular function, physiological system development and function,
and disease and disorder, identifies predominant functions
associated with the network. Statistical significance is calculated
by comparing the number of proteins participating in a given
function with the total number of the proteins known to have this
function in the Ingenuity knowledge base.
ELISA Assays
Apolipoprotein AI (Apo-AI) and Apolipoprotein B (Apo-B)
concentrations were measured by a sandwich ELISA method
using kits (AlerChek Inc, Portland, ME, USA) according to the
manufacturer’s instructions.
Plasma Proteome during PM
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8822Results
Global Plasma Proteome by LC-MS/MS
Our goal in this study was to identify changes in the plasma
proteome of P. falciparum infected pregnant women that are
associated with SA. Plasma samples from 12 malaria-infected
primigravidae (seven with SA and five without SA) and 12 samples
from malaria-infected multigravidae (six with SA and six without
SA) were analyzed. Mean placental parasite densities and mean
hemoglobin levels were similar in the primigravid and multigravid
women included in this study (Table 1).
In areas of high malaria incidence, anemia of primigravid
women is commonly related to malaria while anemia of
multigravid women is more likely to result from nutritional
deficiencies [14]. The inclusion of plasma samples from malaria-
infected primigravid and multigravid women enabled us to identify
plasma proteome changes specific to malaria-associated SA (ie,
found in primigravid but not multigravid women).
Global proteomic analysis yielded a dataset which corresponded
to 2072 distinct proteins. This set was further filtered to include
only those proteins that had at least two peptides detected in 25%
or more of the samples in at least one of the groups. The final
dataset included 156 proteins.
To identify global changes associated with SA, we quantified
protein levels in each sample according to the number of MS/MS
spectra corresponding to each of the proteins (Table S1). Using
spectrum count as a semi-quantitative approach is based on the
model that the number of observed spectra is directly related to the
relative abundance of the protein [12,15]. This model was
previously validated by correlating protein concentrations and
spectrum counts in samples spiked with known amounts of
markers [12,16]. Spectrum count has been used in comparative
analyses of the urine proteome and to determine proteome
changes in different cells under varying growth conditions
[13,17,18]. Although this approach is semi-quantitative, we
applied this tool to identify potential differences among samples
with different clinical presentations that can be further evaluated
using accurate quantitative methods like ELISA.
Based on relative protein abundance, 20 proteins were
downregulated and 4 proteins were upregulated in plasma samples
from primigravidae with SA versus those without SA (Table 2).
GO (gene ontology) analysis for biological function of these
proteins identified enrichment of proteins that have a role as
transporters (Table 2). These differences were not observed in the
comparisons of plasma samples from multigravid women with and
without SA, except for ITIH4 for which the spectrum count was
lower in women with SA (p=.05). Among multigravid women
with SA, 13 other proteins were differentially expressed compared
to multigravid women without anemia (Table S1).
Interaction Networks and Canonical Pathway Analysis
To infer functional implications from the plasma proteome
changes associated with SA during PM, we examined biological
interaction pathways for the 24 differentially expressed proteins,
using Ingenuity Pathways Analysis (IPA) software. Unlike
traditional statistical analysis, pathway analysis provides overall
information related to changes observed under different physio-
logical conditions. Changes in the expression level of multiple
proteins within a pathway increase the confidence that the
differential expression of a single protein using traditional
statistical methods is likely to be associated with the studied
condition [19].
Of the 24 differentially expressed proteins, all were eligible for
network analysis based on information available for each gene in
the IPA Knowledge Base. Two interaction networks were
identified for the proteins associated with SA (Table 3). The
highest scoring network (Figure 1) incorporated 18 out of the 24
differentially expressed proteins (focus molecules) indicated in
Table 2, and the second network incorporated 5 focus molecules.
Four significant functions were associated with these networks:
lipid metabolism (11 proteins, p=6.98610
28), small molecule
biochemistry (16 proteins, p=6.98610
28), molecular transport (14
proteins, p=1.2610
27), and protein synthesis (7 proteins,
p=1.68610
27). By IPA analysis, plasma proteome changes in
malaria-infected primigravidae with SA resulted in alterations of
five canonical pathways, most significantly the acute phase
response signaling pathway. The plasma proteins associated with
SA were represented in this pathway with 11 proteins out of the
178 proteins assigned to the pathway (p=2.77610
216).
ELISA Studies
By global plasma proteomic analysis, the relative abundance of
seven apolipoproteins was lower among malaria-infected primi-
gravidae with SA. Previous studies reported changes in HDL-
cholesterol and LDL-cholesterol during malaria infection. We
verified the changes observed in lipid metabolism proteins by
measuring Apo-AI and Apo-B concentrations (representing HDL-
cholesterol and LDL-cholesterol respectively) by ELISA in a larger
group of samples collected from malaria-infected and uninfected
primigravidae and multigravidae with and without SA (primi-
gravidae n=150; multigravidae n=145). Plasma levels of Apo-AI
were significantly lower in malaria-infected and uninfected
primigravidae with SA versus those without SA (p=0.016,
p=0.015 respectively). Differences in Apo-AI levels between
women with and without SA were not observed among malaria-
infected and uninfected multigravidae (Figure 2A). Among
primigravidae, plasma Apo-AI levels positively correlated with
hemoglobin levels in both malaria-infected and uninfected
women (r=0.285, p=0.014 n=75; r=0.394, p=0.0007, n=75
respectively).
We further analyzed the relationship between SA, ApoA1 levels
and past infection determined by histological examination of
placenta tissue. Of the 75 samples classified as uninfected by
placental blood smear, 28 had a history of past infection based on
the presence of hemozoin deposits in fibrinoid. Apo-AI levels were
higher in samples from uninfected women compared to those with
active or past infection (p=0.05, p=0.0008 respectively). Among
women with a history of PM by placental histology, Apo-AI levels
were similar between those with and without SA (p=0.18). Among
uninfected primigravidae, Apo-AI levels were lower in those with
SA but the difference did not achieve statistical significance
(p=0.06) (Figure 2B). Although Apo-AI levels were not signif-
icantly different between SA and non-anemic women, Apo-AI
remained positively correlated with hemoglobin levels in samples
Table 1. Characteristics of the study population in the mass
spectrometry based proteomics study.
Primigravidae
Mean (SD)
Multigravidae
Mean (SD) P value
Maternal age (yr) 19.4 (1.6) 26.5 (4.5) ,0.0001
Placenta parasitemia (%) 2.2 (2.4) 1.04 (1.4) NS*
Hemoglobin (g/dl) 6.6 (1.96) 8 (2.9) NS*
*NS not significant.
doi:10.1371/journal.pone.0008822.t001
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(r=0.398, p=0.038, n=28; r=0.396, p=0.007, n=47). Defining
placental infection history by placental histology could be limited
by the time interval between infection and delivery. The
correlation between ApoA1 and hemoglobin levels in primigrav-
idae but not in multigravidae suggests that early PM events that
may not be detected by placental histology could have a long term
effect on anemia.
Previous studies suggested that pro-inflammatory cytokines like
TNF-a can decrease levels of Apo-AI [20,21]. Consistent with this,
levels of TNF-a, IL-10 and IL-6 in placental blood (but not
peripheral blood) were inversely correlated with peripheral Apo-
AI levels in malaria-infected primigravidae (r=20.385,
p=0.0017, n=67; r=20.484, p=0.0002, n=62; r=20.353,
p=0.025, n=50 respectively). Among uninfected primigravidae,
levels of TNF-a and IL-10 in placental blood (but not peripheral
blood) were inversely correlated with peripheral Apo-AI levels
(r=20.535, p,.0001, n=70; r=20.289, p=0.02, n=65). TNF-
a remained inversely correlated with Apo-AI levels after excluding
samples with evidence of past infection. Among malaria-infected
multigravid women levels of TNF-a and IL-10 in placental blood
(but not peripheral blood) were similarly inversely correlated with
peripheral Apo-AI (r=20.453, p=0.011, n=24; r=20.392,
p=0.036, n=22 respectively). A correlation between Apo-AI and
cytokine levels was not observed in samples collected from
uninfected multigravid women. During malaria infection, levels
Table 2. Differentially expressed proteins in plasma samples of primigravid women with SA versus those with no SA.
Accession number Gene symbol Ratio SA/No SA P value (Mann-Whitney U test) Protein type
NP_001624.1 AMBP 0.71 0.034 transporter
NP_000030.1 APOA1 0.64 0.042 transporter
NP_001634.1 APOA2 0.30 0.0045 transporter
NP_000375.1 APOB 0.21 0.0145 transporter
NP_001636.1 APOC1 0.45 0.041 transporter
NP_000474.2 APOC2 0.38 0.034 transporter
NP_000031.1 APOC3 0.23 0.0045 transporter
NP_001638.1 APOD 0.65 0.025 transporter
NP_000704.1 BLVRB 5.60 0.0088 enzyme
NP_000706.1 C4BPA 0.42 0.0043 other
NP_000177.2 CFH 0.72 0.041 other
NP_001349.2 DHX15 0.25 0.0067 enzyme
NP_000496.1 F12 1.62 0.05 peptidase
NP_000499.1 FGA 0.31 0.0045 other
NP_005132.2 FGB 0.31 0.0045 other
NP_000500.2 FGG 0.37 0.0118 other
NP_002017.1 FN1 0.22 0.0045 enzyme
NP_066275.3 HPR 5.51 0.0081 peptidase
NP_002209.2 ITIH4 0.57 0.0045 other
NP_000883.2 KLKB1 0.55 0.01 peptidase
NP_005568.1 LPA 0.02 0.0015 other
NP_005800.3 PRDX2 3.20 0.022 enzyme
NP_006503.1 SAA4 0.58 0.049 transporter
NP_006513.1 WNT6 0.40 0.025 other
doi:10.1371/journal.pone.0008822.t002
Table 3. Interaction networks defined by Ingenuity Pathways Analysis.
ID Molecules in Network Score
Focus Molecules in
Network (in bold) Top Functions
1 AMBP, APOA1, APOA2, APOB, APOC1, APOC2, APOC3, APOD,A P O F ,
CFHR1, F12, FERMT2, FGA, FGB, FGG, Fibrin, Fibrinogen, FN1, HDL, HPR
(includes EG:3250), IL1, ITIH4, Jnk, L-cysteine, L-proline, LDL, LPA,N F k B
(complex), P38 MAPK, PKc(s), PRDX2, SAA4, SAA@, Stat3-Stat3, TMPRSS6
47 18 Lipid metabolism
Small molecule biochemistry
Cardiovascular disease
2 AIFI, ANPEP, APCS, ATP6V1B2, BLVRB, C4BPA, C4BPB, CAT, CDKN3, CFH,
chondroitin sulfate A, CKS2, CMA1, CP, CTSK, DHX15, EMR1, heparin,
IGFBP6, IL6, KITLG, KLKB1, LBP, LDLR, LIPC, PRG2 (includes EG:5553),
PROS1, RARRES2, retinoic acid, SAA2, SERPINA5, SMAD5, TPSB2, UBE2C
10 5 Antigen presentation
Cell-mediated immune response
Humoral immune response
doi:10.1371/journal.pone.0008822.t003
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women [8,9], and could explain decreases in Apo-AI levels in these
women.
By MS/MS data, Apo-B was significantly less abundant among
primigravidae with SA (Table 2). Plasma levels of Apo-B measured
by ELISA were significantly lower in both primigravidae and
multigravidae with PM compared to uninfected women (Figure 3).
However, Apo-B levels were similar in women with SA compared
to those without SA.
Discussion
Global proteomic analysis is not limited to the examination of
known set of factors, and therefore has been a transformative
technology that facilitates the identification of novel disease
pathways and markers. In this study we employed mass
spectrometry-based proteomics to better understand pregnancy
malaria pathogenesis by identifying biomarkers associated with
inflammation and anemia during placental malaria. We found that
SA in infected primigravidae is associated with a significant change
in proteins involved in lipid metabolism. Several previous studies
found that severe infections or chronic inflammatory diseases other
than malaria will also modulate the expression of proteins involved
in lipid metabolism. During severe sepsis or chronic inflammation,
pro-inflammatory cytokine and triglyceride (TG) levels are
increased, while HDL-cholesterol, Apo-AI, Apo-B and LPa levels
are decreased [22,23,24,25]. Among patients under intensive care
for severe sepsis, low levels of Apo-AI are associated with
exacerbations of inflammation and poor prognosis [26].
Changes in lipid parameters have also previously been described
in malaria-infected individuals. In several hospital-based studies of
mild and severe malaria cases, TG levels were increased and
HDL-cholesterol levels were decreased [27,28,29,30]. In a study of
asymptomatic children harboring low parasite levels, malaria
treatment was followed by increases in HDL-cholesterol, LDL-
cholesterol and total cholesterol levels, and a decrease in TG
Figure 1. Network of differentially expressed plasma proteins of primigravid women with SA vesus primigravid women without SA.
24 proteins were eligible for network analysis by Ingenuity Pathways Analysis. The top-scoring network, illustrated here, included 18 focus proteins.
Green and red symbols represent proteins that were down- and up-regulated during SA respectively. Gray symbols represent proteins identified in
the study for which the difference in expression level did not achieve statistical significance. Direct and indirect interactions are represented by the
solid and broken lines respectively.
doi:10.1371/journal.pone.0008822.g001
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with improvements in hemoglobin levels or other clinical
parameters.
We earlier showed that SA is associated with high TNF-a levels
in primigravid but not in multigravid women with PM, suggesting
a role for other factors in the pathogenesis of SA. Apo-AI is a
candidate factor for such a role. Apo-AI binds T cells in vitro and
blocks contact with monocytes, thereby playing an anti-inflam-
matory role by inhibiting TNF-a and IL-1b production by
monocytes [32]. Levels of pro-inflammatory cytokines and lipids
change during chronic inflammatory diseases like rheumatoid
arthritis (RA) [33]. Apo-AI levels decrease in the plasma but
increase in synovial fluid of patients with active rheumatoid
arthritis [34]. Immunohistological studies have co-localized Apo-
AI with T lymphocytes and macrophages in the inflamed
synovium from patients with active arthritis but not patients with
inactive arthritis, suggesting that Apo-AI may have a role in
limiting inflammation [35]. In parallel, TNF-a inhibits the
expression of Apo-AI transcription in a dose-dependent manner
[20,21] suggesting a counter-regulatory relationship between
TNF-a and Apo-AI during inflammatory responses.
Cytokines have a major role in stimulating the production of
acute phase proteins (APP) as part of the host immune response to
infection (reviewed in [36]), but prolonged inflammatory immune
responses may be harmful to the host. Like albumin, Apo-AI is
classified as a negative APP. While the role of negative APP is
unclear, reduced levels of negative APP with anti-inflammatory
activity, such as Apo-AI and transthyretin, may promote pro-
inflammatory responses [35,36]. This may be useful during the
acute response to infection, but a prolonged pro-inflammatory
environment may be deleterious to the host, leading to poor
outcomes like anemia and impaired growth [36].
Severalstudieshaveidentifiedassociationsbetweeninflammatory
immune responses and disease severity during malaria infection. In
particular, TNF-a has been found to have both protective and
harmful effects. TNF-a promotes parasite killing and has a
protective role in controlling parasite levels, but high TNF-a levels
have been associated with severe malaria syndromes like severe
anemia and cerebral malaria [8,37,38]. In this study, Apo-AI levels
negatively correlate with TNF-a levels in all women. Among
primigravid women but not multigravid women, Apo-AI levels are
significantly lower during SA. Multigravid women have specific
immunity to placental parasites and are able to rapidly clear the
infection, unlike primigravid women who lack specific immunity
and often experience a prolonged pro-inflammatory state during
PM. Moreover, a previous study demonstrated that the recovery in
plasma lipoprotein levels after P. vivax infection is a slow process,
with levels returning to normal 12 months after treatment [30]. We
propose that the longer duration of PM or more frequent infection
in primigravid women results in longer exposure to a proinflamma-
tory environment that could lead to excessive reductions in Apo-AI
levels and increases in the risk of SA.
Figure 3. Comparison of peripheral plasma levels of Apo-B
between malaria-infected primigravid and multigravid wom-
en. Apo-B in malaria-infected (open boxes) and uninfected (gray boxes)
women stratified by gravidity. Numbers of samples tested (infected,
uninfected) and the significance of the differences between malaria-
infected and uninfected women (P value analyzed by Mann-Whitney U
test): primigravid (75, 75; p=0.0008; multigravid (33, 112; p=,.0001).
The box plots include the median (middle line), interquartile ranges
(box), and 10–90
th percentiles (whiskers).
doi:10.1371/journal.pone.0008822.g003
Figure 2. Comparison of peripheral plasma levels of Apo-A1
between malaria-infected and uninfected women with and
without severe anemia. (A) Apo-AI levels in severely anemic (open
boxes) and non-anemic (gray boxes) women stratified by gravidity and
malaria infection status. Number of samples tested (severely anemic, non-
anemic) and the significance of differences between anemic and non-
anemic women (p value analyzed by Mann-Whitney U test): primigravid,
PM+ (17, 58; p=0.016); primigravid, PM- (27, 48; p=0.015); multigravid,
PM+ (7, 26; p=0.11); multigravid, PM- (54, 58; p=0.6). (B) Apo-AI levels in
severely anemic (open boxes) and non-anemic (gray boxes) primigravid
women stratified by 3 stages of infection: active infection (PM+), past
infection, and no infection (PM-). Number of samples tested (severely
anemic, non-anemic) and the significance of differences between anemic
and non-anemic primigravid women (p value analyzed by Mann-Whitney
Ut e s t ) :P M + (17,58; p=0.016); past infection (11,17; p=0.18); PM- (16,31;
p=0.06). The box plots include the median (middle line), interquartile
ranges (box), and 10-90
th percentiles (whiskers).
doi:10.1371/journal.pone.0008822.g002
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